<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
                      "http://www.w3.org/TR/html4/strict.dtd">
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="generator" content="hypermail 2.1.5, see http://www.hypermail.org/">
<title>Extropians: RE: extropian investment: Alteon (long)</title>
<meta name="Author" content="Rafal Smigrodzki (rafal@smigrodzki.org)">
<meta name="Subject" content="RE: extropian investment: Alteon (long)">
<meta name="Date" content="2003-06-11">
<style type="text/css">
body {color: black; background: #ffffff}
h1.center {text-align: center}
div.center {text-align: center}
</style>
</head>
<body>
<h1>RE: extropian investment: Alteon (long)</h1>
<!-- received="Wed Jun 11 13:19:32 2003" -->
<!-- isoreceived="20030611191932" -->
<!-- sent="Wed, 11 Jun 2003 15:20:52 -0700" -->
<!-- isosent="20030611222052" -->
<!-- name="Rafal Smigrodzki" -->
<!-- email="rafal@smigrodzki.org" -->
<!-- subject="RE: extropian investment: Alteon (long)" -->
<!-- id="OJEHKDIANIFPAJPDBDGLMEMPCEAA.rafal@smigrodzki.org" -->
<!-- charset="us-ascii" -->
<!-- inreplyto="7735CD154061C041B0D0E1D806C5D8A2608FFA@mind.seventhmaze.byz.org" -->
<!-- expires="-1" -->
<p>
<strong>From:</strong> Rafal Smigrodzki (<a href="mailto:rafal@smigrodzki.org?Subject=RE:%20extropian%20investment:%20Alteon%20(long)"><em>rafal@smigrodzki.org</em></a>)<br>
<strong>Date:</strong> Wed Jun 11 2003 - 16:20:52 MDT
</p>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="9890.html">Adrian Tymes: "Re: How best to spend US$200 billion?"</a>
<ul>
<li><strong>Previous message:</strong> <a href="9888.html">Olga Bourlin: "Re: Investing"</a>
<li><strong>In reply to:</strong> <a href="9873.html">Ramez Naam: "extropian investment: Alteon (long)"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="9899.html">Robert J. Bradbury: "RE: extropian investment: Alteon (long)"</a>
<li><strong>Reply:</strong> <a href="9899.html">Robert J. Bradbury: "RE: extropian investment: Alteon (long)"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#9889">[ date ]</a>
<a href="index.html#9889">[ thread ]</a>
<a href="subject.html#9889">[ subject ]</a>
<a href="author.html#9889">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<hr>
<!-- body="start" -->
<p>
&nbsp;Ramez Naam  wrote:
<br>
<p>The potential market for ALT-711 is multiple billions of dollars per year.
<br>
<p>### There is a lot of competition between blood pressure drugs, so even if
<br>
the pie is huge, the slices can get thin. This is a source of uncertainty -
<br>
if ALT-711 develops as something more than just a blood pressure drug in the
<br>
minds of physicians and patients, the gain could be as you say, but
<br>
otherwise sales could be disappointing.
<br>
<p>I have Alteon stock and for now I'm holding on to it, especially after
<br>
reading your analysis. BTW, my purchase of Alteon is an example of using
<br>
generally accessible data to gain above-average return - I did believe that
<br>
AGE formation is a very smart hypothesis ever since I read about it in SciAm
<br>
decades ago, and when Robert Bradbury mentioned Alteon, I had more than just
<br>
a hunch that their drug would work. For the same reasons, well-grounded,
<br>
professional optimism regarding the underlying technology, and not technical
<br>
analysis of the stock itself, I put almost all of my cash in AFFX when they
<br>
were still trading at 16$ a share. I didn't have the sense to sell it when
<br>
they traded at 160, so I have to admit that aside from the narrow use of my
<br>
professional knowledge I am a very clumsy trader.
<br>
<p>Rafal
<br>
<!-- body="end" -->
<hr>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="9890.html">Adrian Tymes: "Re: How best to spend US$200 billion?"</a>
<li><strong>Previous message:</strong> <a href="9888.html">Olga Bourlin: "Re: Investing"</a>
<li><strong>In reply to:</strong> <a href="9873.html">Ramez Naam: "extropian investment: Alteon (long)"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="9899.html">Robert J. Bradbury: "RE: extropian investment: Alteon (long)"</a>
<li><strong>Reply:</strong> <a href="9899.html">Robert J. Bradbury: "RE: extropian investment: Alteon (long)"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#9889">[ date ]</a>
<a href="index.html#9889">[ thread ]</a>
<a href="subject.html#9889">[ subject ]</a>
<a href="author.html#9889">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<!-- trailer="footer" -->
<hr>
<p><small><em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2.1.5</a> 
: Wed Jun 11 2003 - 13:28:39 MDT
</em></small></p>
</body>
</html>
